PORTAL HYPERTENSION
Clinical trials for PORTAL HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PORTAL HYPERTENSION trials appear
Sign up with your email to follow new studies for PORTAL HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hepatitis d drug tested for preventing deadly liver complications
Disease control OngoingThis study investigates whether a new antiviral drug called Bulevirtide can reduce dangerous high pressure in the liver (portal hypertension) in people with both hepatitis B and hepatitis D infections who also have liver scarring (cirrhosis). Researchers are measuring pressure ch…
Matched conditions: PORTAL HYPERTENSION
Sponsor: Hannover Medical School • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
The hidden cost of liver disease: study tracks financial strain on families
Knowledge-focused OngoingThis study aims to understand the financial burden and stress experienced by patients with liver cirrhosis and their family caregivers. It follows 52 participants and their caregivers for 72 weeks, tracking out-of-pocket medical costs, lost work productivity, and overall financia…
Matched conditions: PORTAL HYPERTENSION
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC